Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Jacobs Bruce N.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMar 04, 2024Sale$41.863,934164,664143,907Mar 04, 2024, 06:12 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerJun 02, 2023Option Exercise$2.0810,00020,800115,035Jun 02, 2023, 02:17 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMar 02, 2023Sale$31.001,37042,465104,882Mar 03, 2023, 04:30 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerOct 21, 2022Option Exercise$2.0810,00020,80081,279Oct 24, 2022, 08:00 AM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerOct 17, 2022Option Exercise$2.0810,00020,80071,279Oct 17, 2022, 08:12 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMay 03, 2022Option Exercise$2.0820,00041,60060,814May 03, 2022, 07:26 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerJan 14, 2022Option Exercise$2.0810,00020,80027,514Jan 14, 2022, 05:15 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerJan 12, 2022Option Exercise$2.0815,00031,20032,514Jan 14, 2022, 05:01 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerJan 12, 2022Sale$51.8515,000777,68426,087Jan 14, 2022, 05:01 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerDec 03, 2021Sale$53.5610,000535,63719,801Dec 03, 2021, 06:43 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerDec 03, 2021Option Exercise$2.0810,00020,80027,514Dec 03, 2021, 06:43 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerNov 23, 2021Option Exercise$2.0810,00020,80017,256Nov 23, 2021, 04:59 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerSep 03, 2021Option Exercise$2.0810,00020,80017,256Sep 03, 2021, 05:57 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerSep 03, 2021Sale$60.1210,000601,1808,756Sep 03, 2021, 05:57 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerJun 03, 2021Option Exercise$2.0810,00020,80017,256Jun 04, 2021, 04:16 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerJun 03, 2021Sale$46.8710,000468,69511,494Jun 04, 2021, 04:16 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerApr 13, 2021Option Exercise$2.087,00014,5607,000Apr 13, 2021, 06:37 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMar 11, 2021Option Exercise$2.081,8053,7541,805Mar 15, 2021, 09:08 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMar 11, 2021Sale$60.071,805108,4320Mar 15, 2021, 09:08 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMar 15, 2021Option Exercise$2.088,19517,0468,195Mar 15, 2021, 09:08 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMar 15, 2021Sale$60.178,195493,0960Mar 15, 2021, 09:08 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMar 08, 2021Option Exercise$2.0810,00020,80010,000Mar 08, 2021, 08:01 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMar 08, 2021Sale$50.6510,000506,4702,301Mar 08, 2021, 08:01 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMar 03, 2021Option Exercise$2.0820,00041,60020,000Mar 05, 2021, 05:26 PM
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.Chief Financial OfficerMar 03, 2021Sale$44.7820,000895,63413,119Mar 05, 2021, 05:26 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe